Charles River Laboratories CRL Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Net margin | -3.6%— | —— | 11.5%-0.7pp | 12.2%+1.2pp | |
| Returns | |||||
| Return on equity | -4.4%— | —— | 14.4%-3.2pp | 17.6%+0.8pp | |
| Return on invested capital | 5.3%+1.7pp | 3.6%-4.7pp | 8.2%-1.0pp | 9.2%-1.3pp | |
| Efficiency | |||||
| Asset turnover | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | |
| Liquidity | |||||
| Current ratio | 1.3×-0.1× | 1.4×-0.1× | 1.5×+0.2× | 1.3×+0.1× | |
| Leverage | |||||
| Debt-to-equity | 0.8×0.0× | 0.8×-0.1× | 0.9×-0.2× | 1.1×-0.1× | |
| Net debt / EBITDA | 3.4×+0.2× | 3.2×+0.1× | 3.1×0.0× | 3.1×-0.1× | |
| Per Share | |||||
| Book value per share | $63.85-4.8% | $67.05-4.1% | $69.91+20.5% | $58.02+17.7% | |
| Valuation | |||||
| Market capitalization | $9.82B+4.0% | $9.44B-22.2% | $12.13B+9.4% | $11.09B-41.7% | |
| Price / sales | 2.4×+0.1× | 2.3×-0.6× | 2.9×+0.1× | 2.8×-2.6× | |
| Price / book | 3.1×+0.4× | 2.7×-0.6× | 3.4×-0.4× | 3.7×-3.8× | |
| EV / EBITDA | 17.2×+2.3× | 14.9×-1.2× | 16.1×+1.4× | 14.7×-10.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Charles River Laboratories's profit margins?
- Charles River Laboratories (CRL) runs a 84.7% gross margin and a 13.0% operating margin, with a -4.6% net margin.
- Where do Charles River Laboratories's ratios come from?
- Every ratio is computed from Charles River Laboratories's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
